Phase II study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients
- 1 February 1996
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 37 (1) , 93-96
- https://doi.org/10.1007/bf01806636
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Mitoxantrone, 5-fluorouracil and levo-leucovorin as salvage treatment in advanced breast cancer patientsEuropean Journal Of Cancer, 1994
- Phase II study of mitoxantrone, leucovorin, and infusional fluorouracil for treatment of metastatic breast cancer.Journal of Clinical Oncology, 1991
- Mitoxantrone, fluorouracil, and high-dose leucovorin: an effective, well-tolerated regimen for metastatic breast cancer.Journal of Clinical Oncology, 1991
- 5-Fluorouracil Plus Leucovorin in Women with Metastatic Breast Cancer A Phase II StudyAmerican Journal of Clinical Oncology, 1991
- Randomized clinical trial comparing mitoxantrone with doxorubicin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma.Journal of Clinical Oncology, 1988
- A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.Journal of Clinical Oncology, 1988
- A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma.Journal of Clinical Oncology, 1987
- Clinical trials and drug toxicity in the elderly. The experience of the eastern cooperative oncology groupCancer, 1983
- Combination Chemotherapy for Advanced Breast Cancer: Response and Effect on SurvivalAnnals of Internal Medicine, 1976